GENEREX BIOTECHNOLOGY CORP 4
4 · GENEREX BIOTECHNOLOGY CORP · Filed Nov 1, 2013
Insider Transaction Report
Form 4
FELLOWS STEPHEN
Acting CFO
Transactions
- Award
Common Stock Purchase Option (right to buy)
2013-10-31+845,492→ 845,492 totalExercise: $0.00From: 2014-01-01Exp: 2018-10-31→ Common Stock (845,492 underlying)
Footnotes (1)
- [F1]On October 31, 2013, the Board of Directors of the issuer granted the reporting person options to purchase 845,492 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer effective October 31, 2013. The grant was made pursuant to the terms of the issuer's 2006 stock plan (445,492 options) and the 2001 stock plan (400,000 options).